U.S. News, Released on 5/25/23
Elon Musk’s brain-implant company Neuralink on Thursday said it had received U.S. Food and Drug Administration’s (FDA) approval to launch first-in-human clinical study.
U.S. News, Released on 5/25/23
Elon Musk’s brain-implant company Neuralink on Thursday said it had received U.S. Food and Drug Administration’s (FDA) approval to launch first-in-human clinical study.